Systemic Injections of Cannabidiol Enhance Acetylcholine Levels from Basal Forebrain in Rats
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Systemic Injections of Cannabidiol Enhance Acetylcholine Levels from Basal Forebrain in Rats
Authors
Keywords
Cannabis, Dopamine, Monoamines, Sleep, Wakefulness
Journal
NEUROCHEMICAL RESEARCH
Volume 43, Issue 8, Pages 1511-1518
Publisher
Springer Nature
Online
2018-06-06
DOI
10.1007/s11064-018-2565-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial
- (2018) Philip McGuire et al. AMERICAN JOURNAL OF PSYCHIATRY
- Sleep-Active Neurons: Conserved Motors of Sleep
- (2018) Henrik Bringmann GENETICS
- Sleep-Active Neurons: Conserved Motors of Sleep
- (2018) Henrik Bringmann GENETICS
- New Targets for Schizophrenia Treatment beyond the Dopamine Hypothesis
- (2017) Albert Yang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Lesion of the basal forebrain cholinergic neurons attenuates sleepiness and adenosine after alcohol consumption
- (2017) Rishi Sharma et al. JOURNAL OF NEUROCHEMISTRY
- Septal Cholinergic Neuromodulation Tunes the Astrocyte-Dependent Gating of Hippocampal NMDA Receptors to Wakefulness
- (2017) Thomas Papouin et al. NEURON
- Selective post-training time window for memory consolidation interference of cannabidiol into the prefrontal cortex: Reduced dopaminergic modulation and immediate gene expression in limbic circuits
- (2017) Matheus Teixeira Rossignoli et al. NEUROSCIENCE
- Neuronal and molecular effects of cannabidiol on the mesolimbic dopamine system: Implications for novel schizophrenia treatments
- (2017) Justine Renard et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- A systematic review of the effect of cannabidiol on cognitive function: Relevance to schizophrenia
- (2017) Ashleigh L. Osborne et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Attenuation of early phase inflammation by cannabidiol prevents pain and nerve damage in rat osteoarthritis
- (2017) Holly T. Philpott et al. PAIN
- Cannabidiol in medical marijuana: Research vistas and potential opportunities
- (2017) Carola Rong et al. PHARMACOLOGICAL RESEARCH
- Phytocannabinoids modulate emotional memory processing through interactions with the ventral hippocampus and mesolimbic dopamine system: implications for neuropsychiatric pathology
- (2017) Roger Hudson et al. PSYCHOPHARMACOLOGY
- Cannabidiol Claims and Misconceptions
- (2017) Ethan B. Russo TRENDS IN PHARMACOLOGICAL SCIENCES
- Cannabis, Cannabinoids, and Sleep: a Review of the Literature
- (2017) Kimberly A. Babson et al. Current Psychiatry Reports
- Anticonvulsant Effects of Cannabidiol in Dravet Syndrome
- (2017) Mohamad Koubeissi Epilepsy Currents
- Role of N-Arachidonoyl-Serotonin (AA-5-HT) in Sleep-Wake Cycle Architecture, Sleep Homeostasis, and Neurotransmitters Regulation
- (2017) Eric Murillo-Rodríguez et al. Frontiers in Molecular Neuroscience
- Plastic and Neuroprotective Mechanisms Involved in the Therapeutic Effects of Cannabidiol in Psychiatric Disorders
- (2017) Alline C. Campos et al. Frontiers in Pharmacology
- An Overview on Medicinal Chemistry of Synthetic and Natural Derivatives of Cannabidiol
- (2017) Paula Morales et al. Frontiers in Pharmacology
- Cholinergic Neurons in the Basal Forebrain Promote Wakefulness by Actions on Neighboring Non-Cholinergic Neurons: An Opto-Dialysis Study
- (2016) J. C. Zant et al. JOURNAL OF NEUROSCIENCE
- Prohedonic Effect of Cannabidiol in a Rat Model of Depression
- (2016) Gal Shoval et al. NEUROPSYCHOBIOLOGY
- Cannabidiol Modulates Fear Memory Formation Through Interactions with Serotonergic Transmission in the Mesolimbic System
- (2016) Christopher Norris et al. NEUROPSYCHOPHARMACOLOGY
- Revealing the role of the endocannabinoid system modulators, SR141716A, URB597 and VDM-11, in sleep homeostasis
- (2016) Eric Murillo-Rodríguez et al. NEUROSCIENCE
- The cholinergic forebrain arousal system acts directly on the circadian pacemaker
- (2016) Glenn R. Yamakawa et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Are cannabidiol and Δ9-tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review
- (2015) John M McPartland et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor
- (2015) R B Laprairie et al. BRITISH JOURNAL OF PHARMACOLOGY
- Transdermal cannabidiol reduces inflammation and pain-related behaviours in a rat model of arthritis
- (2015) D.C. Hammell et al. EUROPEAN JOURNAL OF PAIN
- Molecular Targets of Cannabidiol in Neurological Disorders
- (2015) Clementino Ibeas Bih et al. Neurotherapeutics
- Potential Effects of Cannabidiol as a Wake-Promoting Agent
- (2014) Eric Murillo-Rodriguez et al. Current Neuropharmacology
- Neurophysiological evidence for the presence of cannabinoid CB1 receptors in the laterodorsal tegmental nucleus
- (2014) Neeraj Soni et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- The Effect of Cannabidiol on Ischemia/Reperfusion-Induced Ventricular Arrhythmias
- (2014) Ersöz Gonca et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
- Intrahypothalamic injection of cannabidiol increases the extracellular levels of adenosine in nucleus accumbens in rats
- (2014) Stephanie Mijangos-Moreno et al. NEUROSCIENCE RESEARCH
- Selective potentiation of (α4)3(β2)2 nicotinic acetylcholine receptors augments amplitudes of prefrontal acetylcholine- and nicotine-evoked glutamatergic transients in rats
- (2013) Morten Grupe et al. BIOCHEMICAL PHARMACOLOGY
- Effects of cannabidiol on the function of α7-nicotinic acetylcholine receptors
- (2013) Mohamed Mahgoub et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: A role for A2A receptors
- (2013) M. Mecha et al. NEUROBIOLOGY OF DISEASE
- Cannabidiol, a non-psychotropic plant-derived cannabinoid, decreases inflammation in a murine model of acute lung injury: Role for the adenosine A2A receptor
- (2012) Alison Ribeiro et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Effects on sleep and dopamine levels of microdialysis perfusion of cannabidiol into the lateral hypothalamus of rats
- (2011) Eric Murillo-Rodríguez et al. LIFE SCIENCES
- Adenosine, energy metabolism and sleep homeostasis
- (2010) Tarja Porkka-Heiskanen et al. SLEEP MEDICINE REVIEWS
- Blocking GABA-A receptors in the medial septum enhances hippocampal acetylcholine release and behavior in a rat model of diencephalic amnesia
- (2009) Jessica J. Roland et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- The nonpsychoactive cannabis constituent cannabidiol is a wake-inducing agent.
- (2008) Eric Murillo-Rodríguez et al. BEHAVIORAL NEUROSCIENCE
- The diverse CB1and CB2receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin
- (2007) R G Pertwee BRITISH JOURNAL OF PHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started